Immunocore Holdings plc ADR [IMCR] stock prices are up 5.50% to $37.2 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IMCR shares have gain 15.38% over the last week, with a monthly amount glided 15.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Deutsche Bank started tracking the stock with Buy rating on May 27, 2025, and set its price target to $65. On December 13, 2024, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $35 on the stock. Mizuho downgraded its rating to a Neutral and decreased its price target to $38 on November 11, 2024. UBS initiated its recommendation with a Sell and recommended $24 as its price target on October 24, 2024. Guggenheim downgraded its rating to Neutral for this stock on October 07, 2024. In a note dated April 29, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $74 on this stock.
The stock price of Immunocore Holdings plc ADR [IMCR] has been fluctuating between $23.15 and $39.33 over the past year. Currently, Wall Street analysts expect the stock to reach $66.78 within the next 12 months. Immunocore Holdings plc ADR [NASDAQ: IMCR] shares were valued at $37.2 at the most recent close of the market. An investor can expect a potential return of 79.52% based on the average IMCR price forecast.
Analyzing the IMCR fundamentals
The Immunocore Holdings plc ADR [NASDAQ:IMCR] reported sales of 357.71M for trailing twelve months, representing a surge of 31.32%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.05 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.95 points at the first support level, and at 34.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.82, and for the 2nd resistance point, it is at 38.45.
Ratios To Look Out For
It’s worth pointing out that Immunocore Holdings plc ADR [NASDAQ:IMCR]’s Current Ratio is 5.89. As well, the Quick Ratio is 5.86, while the Cash Ratio is 2.87. Considering the valuation of this stock, the price to sales ratio is 5.24, the price to book ratio is 4.85.
Transactions by insiders
Recent insider trading involved BAKER BROS. ADVISORS LP, Director, that happened on Mar 17 ’25 when 0.81 million shares were purchased. affiliate, Brian Di Donato completed a deal on Mar 17 ’25 to buy 100000.0 shares. Meanwhile, affiliate Brian Di Donato bought 56250.0 shares on Mar 14 ’25.
